KNOXVILLE, Tenn. (AP) — Pilot Corporation founder Jim Haslam II will chair the Pat Summitt Foundation's advisory board. Haslam is the father of Tennessee Gov. Bill Haslam and Cleveland Browns owner Jimmy Haslam.

The foundation also announced Tuesday that Kara Lawson of the WNBA's Connecticut Sun and Denver Broncos quarterback Peyton Manning will serve as honorary co-chairs. Lawson played for Summitt at Tennessee from 1999-2003. Manning starred at Tennessee from 1994-97 and was the Heisman Trophy runner-up his senior year.

The Pat Summitt Foundation was established in November 2011 to advance research for the prevention and cure of Alzheimer's disease. Summitt announced in the summer of 2011 that she has early-onset dementia, Alzheimer's type. Summitt stepped down as the Tennessee women's basketball coach last April after winning 1,098 games and eight national titles in 38 seasons, though she remains on staff as head coach emeritus.

"It's not often you get the privilege of working with an icon, particularly on such an important goal," Haslam said in a statement released by the foundation.

The advisory board announced Tuesday includes Summitt's son, Marquette assistant women's basketball coach Tyler Summitt.

Other members of the board include Tennessee chancellor Jimmy Cheek, Big East associate commissioner Danielle Donehew, attorney Dan Holbrook, Tennessee president emeritus Joe Johnson, businesswoman and philanthropist Brenda Lawson, former Lady Vols guard Michelle Marciniak, Mayo Alzheimer's Disease Research Center director Ronald Petersen, retired Tennessee women's associate athletic director of development Betsy Roberts and University of Tennessee Medical Center staff chaplain/pastoral care services Anne Sprouse.

"Almost every family is touched in some way by Alzheimer's disease, and it is our mission to help find a cure as quickly as possible," Haslam said. "You know, Pat Summitt has been a success at everything she has ever taken on, and I truly believe her support will make a huge difference on the national platform for Alzheimer's."